These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38298950)

  • 1. Retracted: Risk Factors of Urinary Pathogenic Bacteria Infection after Benign Prostatic Hyperplasia Surgery and Curative Effect Analysis of Shuangdong Capsule Intervention.
    International EM
    Emerg Med Int; 2024; 2024():9786504. PubMed ID: 38298950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors of Urinary Pathogenic Bacteria Infection after Benign Prostatic Hyperplasia Surgery and Curative Effect Analysis of Shuangdong Capsule Intervention.
    Xu B; Liu M; Liu Y; Zuo J
    Emerg Med Int; 2022; 2022():4069787. PubMed ID: 36119915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Changes in Serum CRP and PCT Levels in Patients with Acute Simple Lower Urinary Tract Infection and Evaluation of the Efficacy of Treatment with Shuangdong Capsules.
    International EM
    Emerg Med Int; 2024; 2024():9850678. PubMed ID: 38298980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9808162. PubMed ID: 37388009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Serum CRP and PCT Levels in Patients with Acute Simple Lower Urinary Tract Infection and Evaluation of the Efficacy of Treatment with Shuangdong Capsules.
    Tang Y; Zhou Q
    Emerg Med Int; 2022; 2022():9750237. PubMed ID: 36052218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Evaluation and Correlation Analysis of Mental and Psychological Factors and Premature Ejaculation in Patients with Benign Prostatic Hyperplasia in Mobile Medical System.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9849308. PubMed ID: 37946822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation.
    Longevity OMAC
    Oxid Med Cell Longev; 2024; 2024():9860941. PubMed ID: 38234571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Nursing Research on Benign Prostatic Hyperplasia Based on Continuous Nursing Care.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9828659. PubMed ID: 37416264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer.
    Tolani MA; Suleiman A; Awaisu M; Abdulaziz MM; Lawal AT; Bello A
    Pan Afr Med J; 2020; 36():169. PubMed ID: 32952813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Therapeutic Effect Analysis of Plasma Bipolar Intelligent Electrotonic for Cystostomy in the Treatment of Senile Prostatic Hyperplasia.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9804341. PubMed ID: 37476729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.
    Toren P; Margel D; Kulkarni G; Finelli A; Zlotta A; Fleshner N
    BMJ; 2013 Apr; 346():f2109. PubMed ID: 23587564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia progression and its impact on treatment.
    Djavan B; Waldert M; Ghawidel C; Marberger M
    Curr Opin Urol; 2004 Jan; 14(1):45-50. PubMed ID: 15091050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Curative Effect of Yangxin Dingji Capsule Combined With Mexiletine Hydrochloride on Postoperative Arrhythmia and Its Influences on the Vascular Endothelial Function in Coronary Bifurcation Lesions.
    International EM
    Emerg Med Int; 2024; 2024():9756981. PubMed ID: 38299003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan.
    Ou SC; Huang ST; Lin MC; Chen WC; Huang CP; Lin HJ
    Int J Urol; 2022 Jul; 29(7):623-630. PubMed ID: 35486019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTED: Alhakamy et al. Attenuation of Benign Prostatic Hyperplasia by Optimized Tadalafil Loaded Pumpkin Seed Oil-Based Self Nanoemulsion: In Vitro and In Vivo Evaluation.
    Alhakamy NA; Fahmy UA; Ahmed OAA
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute urinary retention in men: 21-year trends in incidence, subsequent benign prostatic hyperplasia-related treatment and mortality: A Danish population-based cohort study.
    Bengtsen MB; Heide-Jørgensen U; Borre M; Knudsen JS; Nørgaard M
    Prostate; 2023 Jan; 83(1):87-96. PubMed ID: 36128607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.
    Wilde MI; Fitton A; McTavish D
    Drugs; 1993 Mar; 45(3):410-29. PubMed ID: 7682910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.